Related Experiment Video
Updated: Nov 18, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
The role of N6-methyladenosine mRNA in the tumor microenvironment
Min Li1, Xuan Zha1, Shengjun Wang1
1Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, China; Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
Abstract:
In recent years, the most widely distributed eukaryotic messenger RNA (mRNA) modification, N6-methyladenosine (m6A), has received a large amount of interest, in part due to the development and advances of high-throughput RNA sequencing. The effects of m6A mRNA on tumor progression have been the most widely studied, and large amounts of conflicting data have been reported due to differences in tumor contexts, cell types or cell states. The majority of these studies were related to the significance of m6A mRNA on tumor cells, including on proliferation, stemness, invasion capability, etc. However, it has been noted that tumorigenesis and tumor progression cannot occur without support from the tumor microenvironment (TME), which contains multiple types of stromal cells, such as infiltrating immune cells (IICs), vascular cells, mesenchymal stem cells (MSCs), cancer-associated fibroblasts (CAFs), and various environmental factors. Here, we summarized the contributions of abnormal m6A mRNA in stromal cells within the TME and described the effects of m6A mRNA on TME remodeling.
Insights
N6-methyladenosine (m6A) mRNA modifications in tumor microenvironment (TME) stromal cells significantly impact cancer progression. This review summarizes m6A
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- N6-methyladenosine (m6A) is a prevalent eukaryotic mRNA modification with growing interest due to advanced RNA sequencing.
- While m6A's role in tumor cells is extensively studied, conflicting data exists, highlighting the need to explore other factors.
- Tumorigenesis relies on the tumor microenvironment (TME), comprising stromal cells and environmental factors, which are often overlooked in m6A research.
Purpose of the Study:
- To summarize the role of aberrant N6-methyladenosine (m6A) mRNA modifications in stromal cells within the tumor microenvironment (TME).
- To elucidate the impact of m6A mRNA modifications in stromal cells on TME remodeling and cancer progression.
Main Methods:
- Literature review and synthesis of existing research on m6A mRNA modifications in the TME.
- Analysis of studies investigating the functions of m6A in various stromal cell types (e.g., immune cells, fibroblasts, stem cells).
Main Results:
- Abnormal m6A mRNA levels in TME stromal cells contribute to tumor progression.
- m6A modifications influence the behavior of immune cells, cancer-associated fibroblasts, and other stromal components.
- These modifications play a crucial role in reshaping the TME to support tumor growth and development.
Conclusions:
- m6A mRNA modifications in stromal cells are critical regulators of the tumor microenvironment.
- Targeting m6A pathways in stromal cells presents a potential therapeutic strategy for cancer treatment.
- Further research is needed to fully understand the complex interplay between m6A and TME stromal cells in tumorigenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
The Tumor Microenvironment
Abnormal Proliferation
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
RNA Stability

